BRO

Digging Deeper – A Swift Analysis for BRO Investors

Now trading at a price of $102.0, Brown & Brown has moved -1.6% so far today.

Brown & Brown returned gains of 39.3% last year, with its stock price reaching a high of $103.87 and a low of $66.73. Over the same period, the stock outperformed the S&P 500 index by 12.2%. More recently, the company's 50-day average price was $95.78. Brown & Brown, Inc. markets and sells insurance products and services in the United States, Canada, Ireland, the United Kingdom, and internationally. Based in Daytona Beach, FL, the Large-Cap Finance company has 16,152 full time employees. Brown & Brown has offered a 0.5% dividend yield over the last 12 months.

Strong Revenue Growth but Significant Leverage Levels:

2018 2019 2020 2021 2022 2023
Revenue (M) $2,014 $2,392 $2,613 $3,051 $3,573 $4,257
Interest Income (M) $41 $64 $59 $65 $141 $190
Operating Margins 23% 22% 24% 25% 25% 27%
Net Margins 17% 17% 18% 19% 19% 20%
Net Income (M) $344 $399 $480 $587 $672 $870
Depreciation & Amort. (M) $23 $23 $26 $33 $39 $40
Diluted Shares (M) 276 275 276 277 279 281
Earnings Per Share $1.25 $1.45 $1.74 $2.12 $2.41 $3.1
EPS Growth n/a 16.0% 20.0% 21.84% 13.68% 28.63%
Avg. Price $26.75 $32.48 $41.99 $53.78 $63.5 $102.0
P/E Ratio 21.4 22.87 24.56 25.86 26.68 33.33
Free Cash Flow (M) $526 $605 $642 $764 $829 $941
CAPEX (M) $42 $73 $71 $45 $53 $69
EV / EBITDA 17.5 18.48 20.5 20.78 23.45 27.54
Total Debt (M) $1,557 $1,610 $2,166 $2,065 $4,193 $4,365
Net Debt / EBITDA 2.3 1.94 2.32 1.72 3.87 3.09
Current Ratio 1.22 1.22 1.26 1.25 1.09 1.04

Brown & Brown has rapidly growing revenues and increasing reinvestment in the business and strong operating margins with a stable trend. Additionally, the company's financial statements display generally positive cash flows and a strong EPS growth trend. Furthermore, Brown & Brown has just enough current assets to cover current liabilities, as shown by its current ratio of 1.04 and significant leverage levels.

Brown & Brown's P/B and P/E Ratios Are Higher Than Average:

Brown & Brown has a trailing twelve month P/E ratio of 27.6, compared to an average of 19.48 for the Finance sector. Based on its EPS guidance of $4.04, the company has a forward P/E ratio of 23.7. Brown & Brown's PEG ratio is 2.12 on the basis of the 13.0% weighted average of the company and the broader market's EPS compound average growth rates. This suggests that the company's shares are overvalued. Furthermore, Brown & Brown is likely overvalued compared to the book value of its equity, since its P/B ratio of 4.82 is higher than the sector average of 1.85. The company's shares are currently trading 174.0% below their Graham number. Overall, Brown & Brown's lofty valuation in terms of earnings and assets is to some extent attenuated by its strong cash flow trend and reasonable levels of debt.

Brown & Brown Has an Average Rating of Buy:

The 12 analysts following Brown & Brown have set target prices ranging from $92.0 to $112.0 per share, for an average of $105.2 with a buy rating. The company is trading -3.0% away from its average target price, indicating that there is an analyst consensus of some upside potential.

Brown & Brown has a very low short interest because 1.2% of the company's shares are sold short. Institutions own 75.5% of the company's shares, and the insider ownership rate stands at 16.35%, suggesting a large amount of insider shareholders. The largest shareholder is Vanguard Group Inc, whose 10% stake in the company is worth $2,926,946,406.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS